202 related articles for article (PubMed ID: 34212451)
41. PCDH19-related epilepsy is associated with a broad neurodevelopmental spectrum.
Smith L; Singhal N; El Achkar CM; Truglio G; Rosen Sheidley B; Sullivan J; Poduri A
Epilepsia; 2018 Mar; 59(3):679-689. PubMed ID: 29377098
[TBL] [Abstract][Full Text] [Related]
42. Genomic analysis of multiplex consanguineous families reveals causes of neurodevelopmental disorders with epilepsy.
Shafique A; Sultan T; Alzahrani F; Hun Seo G; Alkuraya FS; Naz S
Gene; 2023 Aug; 879():147599. PubMed ID: 37393059
[TBL] [Abstract][Full Text] [Related]
43. Delineation of functionally essential protein regions for 242 neurodevelopmental genes.
Iqbal S; Brünger T; Pérez-Palma E; Macnee M; Brunklaus A; Daly MJ; Campbell AJ; Hoksza D; May P; Lal D
Brain; 2023 Feb; 146(2):519-533. PubMed ID: 36256779
[TBL] [Abstract][Full Text] [Related]
44. Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.
Kosmicki JA; Samocha KE; Howrigan DP; Sanders SJ; Slowikowski K; Lek M; Karczewski KJ; Cutler DJ; Devlin B; Roeder K; Buxbaum JD; Neale BM; MacArthur DG; Wall DP; Robinson EB; Daly MJ
Nat Genet; 2017 Apr; 49(4):504-510. PubMed ID: 28191890
[TBL] [Abstract][Full Text] [Related]
45. Mutations in TBR1 gene leads to cortical malformations and intellectual disability.
Vegas N; Cavallin M; Kleefstra T; de Boer L; Philbert M; Maillard C; Boddaert N; Munnich A; Hubert L; Bery A; Besmond C; Bahi-Buisson N
Eur J Med Genet; 2018 Dec; 61(12):759-764. PubMed ID: 30268909
[TBL] [Abstract][Full Text] [Related]
46. DYNC1H1 variants associated with infant-onset epilepsy without neurodevelopmental disorders.
Wu WC; Liang XY; Zhang DM; Jin L; Liu ZG; Zeng XL; Zhai QX; Liao WP; He N; Meng XH
Seizure; 2024 Mar; 116():119-125. PubMed ID: 37903666
[TBL] [Abstract][Full Text] [Related]
47. Biallelic INTS1 Mutations Cause a Rare Neurodevelopmental Disorder in Two Chinese Siblings.
Zhang X; Wang Y; Yang F; Tang J; Xu X; Yang L; Yang XA; Wu D
J Mol Neurosci; 2020 Jan; 70(1):1-8. PubMed ID: 31428919
[TBL] [Abstract][Full Text] [Related]
48. Complex Autism Spectrum Disorder with Epilepsy, Strabismus and Self-Injurious Behaviors in a Patient with a De Novo Heterozygous
Evans DR; Qiao Y; Trost B; Calli K; Martell S; Jones SJM; Scherer SW; Lewis MES
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328024
[TBL] [Abstract][Full Text] [Related]
49. Neurodevelopmental disorder associated with de novo SCN3A pathogenic variants: two new cases and review of the literature.
Inuzuka LM; Macedo-Souza LI; Della-Ripa B; Cabral KSS; Monteiro F; Kitajima JP; de Souza Godoy LF; de Souza Delgado D; Kok F; Garzon E
Brain Dev; 2020 Feb; 42(2):211-216. PubMed ID: 31677917
[TBL] [Abstract][Full Text] [Related]
50. A novel likely pathogenic heterozygous HECW2 missense variant in a family with variable expressivity of neurodevelopmental delay, hypotonia, and epileptiform EEG patterns.
Heide EC; Puk O; Biskup S; Krahn A; Rauf E; Kreilkamp BAK; Paulus W; Focke NK
Am J Med Genet A; 2021 Dec; 185(12):3838-3843. PubMed ID: 34327820
[TBL] [Abstract][Full Text] [Related]
51. Rare and de novo duplications containing TCF20 are associated with a neurodevelopmental disorder.
Lévy J; Cogan G; Maruani A; Maillard A; Dupont C; Drunat S; Rachid M; Atzori P; Delorme R; Jeyarajah S; Isidor B; Pichon O; Moradkhani K; Verloes A; Tabet AC
Clin Genet; 2022 Mar; 101(3):364-370. PubMed ID: 34904221
[TBL] [Abstract][Full Text] [Related]
52. A de novo missense variant in GABRA4 alters receptor function in an epileptic and neurodevelopmental phenotype.
Vogel FD; Krenn M; Westphal DS; Graf E; Wagner M; Leiz S; Koniuszewski F; Augé-Stock M; Kramer G; Scholze P; Ernst M
Epilepsia; 2022 Apr; 63(4):e35-e41. PubMed ID: 35152403
[TBL] [Abstract][Full Text] [Related]
53. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain.
Marbach F; Stoyanov G; Erger F; Stratakis CA; Settas N; London E; Rosenfeld JA; Torti E; Haldeman-Englert C; Sklirou E; Kessler E; Ceulemans S; Nelson SF; Martinez-Agosto JA; Palmer CGS; Signer RH; ; Andrews MV; Grange DK; Willaert R; Person R; Telegrafi A; Sievers A; Laugsch M; Theiß S; Cheng Y; Lichtarge O; Katsonis P; Stocco A; Schaaf CP
Genet Med; 2021 Aug; 23(8):1465-1473. PubMed ID: 33833410
[TBL] [Abstract][Full Text] [Related]
54. Dysfunction of the Cerebral Glucose Transporter SLC45A1 in Individuals with Intellectual Disability and Epilepsy.
Srour M; Shimokawa N; Hamdan FF; Nassif C; Poulin C; Al Gazali L; Rosenfeld JA; Koibuchi N; Rouleau GA; Al Shamsi A; Michaud JL
Am J Hum Genet; 2017 May; 100(5):824-830. PubMed ID: 28434495
[TBL] [Abstract][Full Text] [Related]
55. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.
Stolz JR; Foote KM; Veenstra-Knol HE; Pfundt R; Ten Broeke SW; de Leeuw N; Roht L; Pajusalu S; Part R; Rebane I; Õunap K; Stark Z; Kirk EP; Lawson JA; Lunke S; Christodoulou J; Louie RJ; Rogers RC; Davis JM; Innes AM; Wei XC; Keren B; Mignot C; Lebel RR; Sperber SM; Sakonju A; Dosa N; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Ruivenkamp CAL; van Bon BW; Kennedy J; Low KJ; Ellard S; Pang L; Junewick JJ; Mark PR; Carvill GL; Swanson GT
Am J Hum Genet; 2021 Sep; 108(9):1692-1709. PubMed ID: 34375587
[TBL] [Abstract][Full Text] [Related]
56. De novo POLR2A p.(Ile457Thr) variant associated with early-onset encephalopathy and cerebellar atrophy: expanding the phenotypic spectrum.
Giacomini T; Scala M; Nobile G; Severino M; Tortora D; Nobili L; Accogli A; Torella A; Capra V; Mancardi MM; Nigro V;
Brain Dev; 2022 Aug; 44(7):480-485. PubMed ID: 35461703
[TBL] [Abstract][Full Text] [Related]
57. De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia.
Berko ER; Cho MT; Eng C; Shao Y; Sweetser DA; Waxler J; Robin NH; Brewer F; Donkervoort S; Mohassel P; Bönnemann CG; Bialer M; Moore C; Wolfe LA; Tifft CJ; Shen Y; Retterer K; Millan F; Chung WK
J Med Genet; 2017 Feb; 54(2):84-86. PubMed ID: 27389779
[TBL] [Abstract][Full Text] [Related]
58. Variant recurrence in neurodevelopmental disorders: the use of publicly available genomic data identifies clinically relevant pathogenic missense variants.
Lecoquierre F; Duffourd Y; Vitobello A; Bruel AL; Urteaga B; Coubes C; Garret P; Nambot S; Chevarin M; Jouan T; Moutton S; ; Tran-Mau-Them F; Philippe C; Sorlin A; Faivre L; Thauvin-Robinet C
Genet Med; 2019 Nov; 21(11):2504-2511. PubMed ID: 31036916
[TBL] [Abstract][Full Text] [Related]
59. Reprint of: Recessive APC2 missense variants associated with epilepsies without neurodevelopmental disorders.
Jin L; Li Y; Luo S; Peng Q; Zhai QX; Zhai JX; Gao LD; Guo JJ; Song W; Yi YH; He N; Chen YJ
Seizure; 2024 Mar; 116():87-92. PubMed ID: 38523034
[TBL] [Abstract][Full Text] [Related]
60. Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progression.
Jimenez-Gomez A; Niu S; Andujar-Perez F; McQuade EA; Balasa A; Huss D; Coorg R; Quach M; Vinson S; Risen S; Holder JL
J Neurodev Disord; 2019 Aug; 11(1):18. PubMed ID: 31395010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
